Cargando...
Immunosuppressive mechanisms in glioblastoma
Despite maximal surgical and medical therapy, the treatment of glioblastoma remains a seriously vexing problem, with median survival well under 2 years and few long-term survivors. Targeted therapy has yet to produce significant advances in treatment of these lesions in spite of advanced molecular c...
Guardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Oxford University Press
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4625890/ https://ncbi.nlm.nih.gov/pubmed/26516226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov151 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|